11.15
-0.08 (-0.69%)
| Previous Close | 11.23 |
| Open | 11.34 |
| Volume | 14,465,329 |
| Avg. Volume (3M) | 10,669,100 |
| Market Cap | 7,603,666,944 |
| Price / Earnings (Forward) | 8.65 |
| Price / Sales | 0.820 |
| Price / Book | 0.970 |
| 52 Weeks Range | |
| Earnings Date | 11 Feb 2026 |
| Profit Margin | 10.70% |
| Operating Margin (TTM) | 8.21% |
| Diluted EPS (TTM) | 1.04 |
| Quarterly Revenue Growth (YOY) | -5.90% |
| Quarterly Earnings Growth (YOY) | 6.80% |
| Total Debt/Equity (MRQ) | 67.34% |
| Current Ratio (MRQ) | 1.12 |
| Operating Cash Flow (TTM) | 808.50 M |
| Levered Free Cash Flow (TTM) | 751.08 M |
| Return on Assets (TTM) | 3.53% |
| Return on Equity (TTM) | 12.52% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Mixed | Bearish | |
| Stock | Avantor, Inc. | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | -0.5 |
| Insider Activity | 1.5 |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.5 |
| Average | -0.70 |
|
Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Value |
| % Held by Insiders | 1.35% |
| % Held by Institutions | 103.17% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| New Mountain Capital, L.L.C. | 30 Sep 2025 | 14,000,000 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 14.00 (Wells Fargo, 25.54%) | Buy |
| Median | 12.00 (7.60%) | |
| Low | 8.50 (Barclays, -23.78%) | Sell |
| Average | 11.50 (3.12%) | |
| Total | 1 Buy, 3 Hold, 1 Sell | |
| Avg. Price @ Call | 10.10 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Barclays | 06 Mar 2026 | 8.50 (-23.78%) | Sell | 8.17 |
| 12 Feb 2026 | 9.00 (-19.30%) | Hold | 9.14 | |
| Wells Fargo | 13 Feb 2026 | 14.00 (25.54%) | Buy | 9.20 |
| Citigroup | 12 Feb 2026 | 11.00 (-1.36%) | Hold | 9.14 |
| TD Cowen | 07 Jan 2026 | 12.00 (7.60%) | Hold | 12.08 |
| Evercore ISI Group | 05 Jan 2026 | 12.00 (7.60%) | Hold | 11.89 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| MEHRA SANJEEV K | 8.15 | - | 125,000 | 1,018,750 |
| Aggregate Net Quantity | 125,000 | |||
| Aggregate Net Value ($) | 1,018,750 | |||
| Aggregate Avg. Buy ($) | 8.15 | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| MEHRA SANJEEV K | Director | 10 Mar 2026 | Buy (+) | 125,000 | 8.15 | 1,018,750 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |